Table 5.
Compound | Starting inhibitor concentration [µM] | Method | Observation wavelength [nm] | Intracellular accumulation [µM] | t-test |
---|---|---|---|---|---|
PLP | 390 | UV absorption | 388 | 84.7 ± 17.6 after 4 h 100.4 ± 16.3 after 8 h |
**** |
PI-h | 325 | UV absorption | 318 | −8.9 ± 4.9 after 4 h −10.1 ± 8.2 after 8 h |
ns |
35.4 | UV absorption | 318 | −1.88 ± 0.77 after 4 h 0.80 ± 0.53 after 8 h |
ns | |
ns | |||||
35.4 | LC-MS | – | 0.10 ± 0.84 after 4 h 3.58 ± 0.55 after 8 h |
ns *** |
Notes: The extracellular inhibitor concentration was determined by UV absorption spectra of the tested compounds and LC-MS detection methods 17. The t-test was used to check for a significant difference in the extracellular inhibitor concentration between supernatants incubated with and without H. pylori cells. The intracellular accumulation of each compound was determined using Equation (3) as described in the text. Results of the t-test are marked as follows: **** p < 0.0001; *** p < 0.001; ns p > 0.05, no significant difference.